TEST BANK FOR PHARMACOTHERAPEUT
n n n
ICS FOR ADVANCED PRACTICE-
n n n
A PRACTICAL APPROACH 5TH EDITION A
n n n n n n
RCANGELO FULL TESTBANK LATELY UP
n n n n
DATED 2025 WITH VERIFIED SOLUTIONS||
n n n n n
GUARANTEED PASS!!! n
,1n|nPn an gn e
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCED PRACTI
n n n n n n
CE-
A PRACTICAL APPROACH 5TH EDITION ARCANGELO FULL TESTBANK
n n n n n n n n n
LATELY UPDATED 2025 WITH VERIFIED SOLUTIONS|| GUARANTEED PA
n n n n n n n
SS!!!
Chapter 01: Issues for the Practitioner in Drug Therapy MULTIPLE
n n n n n n n n n
n CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
n n n n n n
A. The National Council of State Boards of Nursing
n n n n n n n
B. The U.S. Drug Enforcement Administration
n n n n
C. The State Board of Nursing for each state
n n n n n n n
D. The State Board of Pharmacy
n n n n
ANSWER_ C n POINTS: 1 n
2. Physician Assistant (PA) prescriptive authority is regulated by:
n n n n n n n
A. The National Council of State Boards of Nursing
n n n n n n n
B. The U.S. Drug Enforcement Administration
n n n n
C. The State Board of Nursing
n n n n
D. The State Board of Medical Examiners
n n n n n
ANSWER_ D n POINTS: 1 n
3. Clinical judgment in prescribing includes:
n n n n
A. Factoring in the cost to the patient of the medication prescribed
n n n n n n n n n n
B. Always prescribing the newest medication available for the disease process
n n n n n n n n n
C. Handing out drug samples to poor patients
n n n n n n
D. Prescribing all generic medications to cut costs
n n n n n n
,2n|nPn an gn e
ANSWER_ A n POINTS: 1 n
4. Criteria for choosing an effective drug for a disorder include:
n n n n n n n n n
A. Asking the patient what drug they think would work best for them
n n n n n n n n n n n
B. Consulting nationally recognized guidelines for disease management
n n n n n n
C. Prescribing medications that are available as samples before writing a p
n n n n n n n n n n
rescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
n n n n n n n n
prescribing
ANSWER_ B n POINTS: 1 n
5. Nurse practitioner practice may thrive under health-care reform due to:
n n n n n n n n n
A. The demonstrated ability of nurse practitioners to control costs and improve p
n n n n n n n n n n n
atient outcomes
n
B. The fact that nurse practitioners will be able to practice independently
n n n n n n n n n n
C. The fact that nurse practitioners will have full reimbursement under health-
n n n n n n n n n n
care reform
n n
D. The ability to shift accountability for Medicaid to the state level
n n n n n n n n n n
ANSWER_ A n POINTS: 1 n
Chapter 02: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic MULTI
n n n n n n n n
PLE CHOICE
n
1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This is c
n n n n n n n n n n n
ritical to prescribing because:
n n n
A. Distribution of drugs to target tissue may be affected
n n n n n n n n
B. The solubility of the drug will not match the site of absorption
n n n n n n n n n n n
, 3n|nPn an gn e
C. There will be less free drug available to generate an effect
n n n n n n n n n n
D. Drugs bound to albumin are readily excreted by the kidney
n n n n n n n n n
ANSWER_ A n POINTS: 1 n
2. Drugs that have a significant first-pass effect:
n n n n n n
A. Must be given by the enteral (oral) route only
n n n n n n n n
B. Bypass the hepatic circulation
n n n
C. Are rapidly metabolized by the liver and may have little if any desired action
n n n n n n n n n n n n n
D. Are converted by the liver to more active and fat-soluble forms
n n n n n n n n n n
ANSWER_ C n POINTS: 1 n
3. The route of excretion of a volatile drug will likely be:
n n n n n n n n n n
A. The kidneys
n
B. The lungs
n
C. The bile and feces
n n n
D. The skin
n
ANSWER_ B n POINTS: 1 n
4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage r n n n n n n n n n n
eservoir of the drug. Storage reservoirs:
n n n n n
A. Assure that the drug will reach its intended target tissue
n n n n n n n n n
B. Are the reason for giving loading doses
n n n n n n
C. Increase the length of time a drug is available and active
n n n n n n n n n n
D. Are most common in collagen tissues
n n n n n
ANSWER_ C n POINTS: 1 n
n n n
ICS FOR ADVANCED PRACTICE-
n n n
A PRACTICAL APPROACH 5TH EDITION A
n n n n n n
RCANGELO FULL TESTBANK LATELY UP
n n n n
DATED 2025 WITH VERIFIED SOLUTIONS||
n n n n n
GUARANTEED PASS!!! n
,1n|nPn an gn e
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCED PRACTI
n n n n n n
CE-
A PRACTICAL APPROACH 5TH EDITION ARCANGELO FULL TESTBANK
n n n n n n n n n
LATELY UPDATED 2025 WITH VERIFIED SOLUTIONS|| GUARANTEED PA
n n n n n n n
SS!!!
Chapter 01: Issues for the Practitioner in Drug Therapy MULTIPLE
n n n n n n n n n
n CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
n n n n n n
A. The National Council of State Boards of Nursing
n n n n n n n
B. The U.S. Drug Enforcement Administration
n n n n
C. The State Board of Nursing for each state
n n n n n n n
D. The State Board of Pharmacy
n n n n
ANSWER_ C n POINTS: 1 n
2. Physician Assistant (PA) prescriptive authority is regulated by:
n n n n n n n
A. The National Council of State Boards of Nursing
n n n n n n n
B. The U.S. Drug Enforcement Administration
n n n n
C. The State Board of Nursing
n n n n
D. The State Board of Medical Examiners
n n n n n
ANSWER_ D n POINTS: 1 n
3. Clinical judgment in prescribing includes:
n n n n
A. Factoring in the cost to the patient of the medication prescribed
n n n n n n n n n n
B. Always prescribing the newest medication available for the disease process
n n n n n n n n n
C. Handing out drug samples to poor patients
n n n n n n
D. Prescribing all generic medications to cut costs
n n n n n n
,2n|nPn an gn e
ANSWER_ A n POINTS: 1 n
4. Criteria for choosing an effective drug for a disorder include:
n n n n n n n n n
A. Asking the patient what drug they think would work best for them
n n n n n n n n n n n
B. Consulting nationally recognized guidelines for disease management
n n n n n n
C. Prescribing medications that are available as samples before writing a p
n n n n n n n n n n
rescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
n n n n n n n n
prescribing
ANSWER_ B n POINTS: 1 n
5. Nurse practitioner practice may thrive under health-care reform due to:
n n n n n n n n n
A. The demonstrated ability of nurse practitioners to control costs and improve p
n n n n n n n n n n n
atient outcomes
n
B. The fact that nurse practitioners will be able to practice independently
n n n n n n n n n n
C. The fact that nurse practitioners will have full reimbursement under health-
n n n n n n n n n n
care reform
n n
D. The ability to shift accountability for Medicaid to the state level
n n n n n n n n n n
ANSWER_ A n POINTS: 1 n
Chapter 02: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic MULTI
n n n n n n n n
PLE CHOICE
n
1. A patient's nutritional intake and lab work reflects hypoalbuminemia. This is c
n n n n n n n n n n n
ritical to prescribing because:
n n n
A. Distribution of drugs to target tissue may be affected
n n n n n n n n
B. The solubility of the drug will not match the site of absorption
n n n n n n n n n n n
, 3n|nPn an gn e
C. There will be less free drug available to generate an effect
n n n n n n n n n n
D. Drugs bound to albumin are readily excreted by the kidney
n n n n n n n n n
ANSWER_ A n POINTS: 1 n
2. Drugs that have a significant first-pass effect:
n n n n n n
A. Must be given by the enteral (oral) route only
n n n n n n n n
B. Bypass the hepatic circulation
n n n
C. Are rapidly metabolized by the liver and may have little if any desired action
n n n n n n n n n n n n n
D. Are converted by the liver to more active and fat-soluble forms
n n n n n n n n n n
ANSWER_ C n POINTS: 1 n
3. The route of excretion of a volatile drug will likely be:
n n n n n n n n n n
A. The kidneys
n
B. The lungs
n
C. The bile and feces
n n n
D. The skin
n
ANSWER_ B n POINTS: 1 n
4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage r n n n n n n n n n n
eservoir of the drug. Storage reservoirs:
n n n n n
A. Assure that the drug will reach its intended target tissue
n n n n n n n n n
B. Are the reason for giving loading doses
n n n n n n
C. Increase the length of time a drug is available and active
n n n n n n n n n n
D. Are most common in collagen tissues
n n n n n
ANSWER_ C n POINTS: 1 n
